1 Min Read
July 23 (Reuters) - Biogen Idec Inc : * Says EU has approved its Plegridy drug for multiple sclerosis. Medicine is a pegylated form of interferon given by injection once every two weeks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.